The report examines trends in the healthcare industry affecting hospital finances. Moody's found that although many hospitals are experiencing stronger revenue growth and more are expected to achieve ...

BISMARCK, N.D. ( North Dakota Monitor) – North Dakota lawmakers voted Thursday to reimburse Sen. Janne Myrdal for the nearly ...

The underwriter has been granted a 30-day option to purchase up to an additional 1,590,000 shares of Ventas's common stock. If such option is exercised, then Ventas plans to enter into an additional ...

Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm ...

Accordingly, we urge fellow Minority Shareholders to vote AGAINST the Transaction by submitting a duly completed form of proxy by 1 ... Pender may seek reimbursement from the Company for out-of-pocket ...

Envoy Medical®, Inc. ("Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing devices, today announces its corporate and financial results for the ...

Good afternoon, and welcome to Fractyl Health's Third Quarter Financial Results and Business Updates Call. As a reminder, this conference call is being recorded. [Operator Instructions]. I will now ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activity M ...

Vivos Therapeutics, Inc. ( NASDAQ: VVOS) Q3 2024 Earnings Conference Call November 14, 2024 5:00 PM ET Kirk Huntsman - Chariman & CEO Brad Amman - CFO Scott Henry - Alliance Global Partners Lucas Ward ...

Envoy Medical®, Inc. ("Envoy Medical") (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing devices, today ...

bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today reported third quarter results and business highlights for the quarter ended September 30, 2024, including recent commercial ...